New Jersey Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Jersey Health Reporter.

Press releases published on September 29, 2026

Sep. 29, 2026

Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry

Indeterminate GlobeNewswire

Sep. 29, 2026

Azurity Pharmaceuticals Showcases Growth and Commercial Momentum ahead of CPHI Milan 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

GATC Health's Derisq Named One of The Scientist's 2026 Top Innovations

Indeterminate GlobeNewswire

Sep. 29, 2026

Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting

Indeterminate GlobeNewswire

Sep. 29, 2026

Lite Strategy Reports Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 29, 2026

Celularity Announces Naveen Jain to Join Board of Directors

Indeterminate GlobeNewswire

Sep. 29, 2026

TOMI Environmental Solutions Targets Next Phase of Growth in the Scaling Robotaxi, Drone and Robotics Economy

Indeterminate GlobeNewswire

Sep. 29, 2026

J-Star Holding Co., Ltd. Chairman and CEO Jonathan Chiang to Relocate to the United States to Lead Growth Initiatives

Indeterminate GlobeNewswire

Sep. 29, 2026

AI-Powered Liquid Biopsy Emerges as a High-Stakes Frontier in Precision Oncology, Attracting Hundreds of Millions in Venture and Public Funding

Indeterminate GlobeNewswire

Sep. 29, 2026

Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis

Indeterminate GlobeNewswire

Sep. 29, 2026

Silexion Therapeutics Announces Exercise of Warrants

Indeterminate GlobeNewswire

Sep. 29, 2026

BIO-Europe 2026 to Convene Global Biopharma Decision-Makers in Cologne

Indeterminate GlobeNewswire

Sep. 29, 2026

argenx Presents New Data at AANEM and MGFA Scientific Session Showcasing Earlier and Sustained Treatment in MG and CIDP with VYVGART and Progress Across its Neuromuscular Pipeline

Indeterminate GlobeNewswire

Sep. 29, 2026

Keros Therapeutics to Receive Additional Development Milestone Payment from Partner Takeda

Indeterminate GlobeNewswire

Sep. 29, 2026

Dianthus Therapeutics Highlights Claseprubart Data Presentations Planned for 2026 AANEM Annual Meeting

Indeterminate GlobeNewswire

Sep. 29, 2026

Nasus Pharma Announces Enrollment and Dosing of First Patient in Phase 1 Study of NS003 Intranasal Formulation of Ondansetron

Indeterminate GlobeNewswire

Sep. 29, 2026

DiFusion to Define Therapeutic Biomaterials Category at NASS 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Illume Fertility Advances Access to LGBTQ+ Family Building at Men Having Babies New York Annual Conference

Indeterminate GlobeNewswire

Sep. 29, 2026

Beta Bionics to Announce Third Quarter 2026 Financial Results on October 27, 2026

Indeterminate GlobeNewswire

Sep. 29, 2026

Pentagon Pivots on Havana Syndrome with Re-Branding, Compensation, and a New Study

Indeterminate GlobeNewswire